Miluna Acquisition Corp. operates as a Special Purpose Acquisition Company (SPAC), a shell entity established with the sole purpose of executing a major business combination. Its primary objective is to merge with, acquire assets or equity from, or undertake a corporate restructuring with one or more existing enterprises. The company was founded on June 24, 2025, and has its main office situated in Taipei, Taiwan.
MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor
MindMaze Therapeutics appointed Prof. John W. Krakauer as a strategic advisor to support its next phase of growth in the United States.
Dr. Krakauer is the original scientific creator of MindPod and a leading researcher in motor neuroscience, bringing significant credibility to the company's neurorehabilitation platform.
The appointment follows recent momentum including a two-year RWE program showing a 60% increase in delivered therapy per day and the establishment of a U.S. headquarters in Charlotte.